TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
Applying clinical prediction rules correctly when treating patients with venous thromboembolism in primary care was found to be associated with low failure rate.
A population-based analysis suggested that plasma levels of von Willebrand factor may be a potential biomarker for the future risk of incident venous thromboembolism.
Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
A novel diagnostic algorithm was able to safely rule out DVT in patients visiting an emergency department, thereby reducing the need for ultrasound imaging.
